These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Understanding and managing Cognition in the Depressed Patient. Papakostas GI; Culpepper L J Clin Psychiatry; 2015 Apr; 76(4):418-25. PubMed ID: 25919832 [TBL] [Abstract][Full Text] [Related]
3. On 'cognitive dysfunction' as a novel target for antidepressant treatment. Impey B; Baldwin DS Hum Psychopharmacol; 2013 Nov; 28(6):535-7. PubMed ID: 24519689 [No Abstract] [Full Text] [Related]
4. Cognition as a target in major depression: new developments. Solé B; Jiménez E; Martinez-Aran A; Vieta E Eur Neuropsychopharmacol; 2015 Feb; 25(2):231-47. PubMed ID: 25640673 [TBL] [Abstract][Full Text] [Related]
7. Mood, psychomotor, and cognitive function in major depressive disorder: from biomarkers to rapid-acting antidepressants. Hashimoto K Eur Arch Psychiatry Clin Neurosci; 2019 Oct; 269(7):759-760. PubMed ID: 31456036 [No Abstract] [Full Text] [Related]
8. The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Rosenblat JD; Kakar R; McIntyre RS Int J Neuropsychopharmacol; 2015 Jul; 19(2):. PubMed ID: 26209859 [TBL] [Abstract][Full Text] [Related]
9. Cognition in major depressive disorder: a 'Systemically Important Functional Index' (SIFI). McIntyre RS; Lee Y Curr Opin Psychiatry; 2016 Jan; 29(1):48-55. PubMed ID: 26575300 [TBL] [Abstract][Full Text] [Related]
10. Neuropsychiatric symptoms in Lewy body diffuse disease: a case report. Salazar G; Cuello D; Fragoso M; Benlloc L Neurologia; 2011 Oct; 26(8):499-502. PubMed ID: 21477898 [No Abstract] [Full Text] [Related]
11. Cognitive remission: a novel objective for the treatment of major depression? Bortolato B; Miskowiak KW; Köhler CA; Maes M; Fernandes BS; Berk M; Carvalho AF BMC Med; 2016 Jan; 14():9. PubMed ID: 26801406 [TBL] [Abstract][Full Text] [Related]
12. The neurogenic compound, NSI-189 phosphate: a novel multi-domain treatment capable of pro-cognitive and antidepressant effects. McIntyre RS; Johe K; Rong C; Lee Y Expert Opin Investig Drugs; 2017 Jun; 26(6):767-770. PubMed ID: 28460574 [TBL] [Abstract][Full Text] [Related]
13. Cognitive impairment in major depressive disorder. Pan Z; Park C; Brietzke E; Zuckerman H; Rong C; Mansur RB; Fus D; Subramaniapillai M; Lee Y; McIntyre RS CNS Spectr; 2019 Feb; 24(1):22-29. PubMed ID: 30468135 [TBL] [Abstract][Full Text] [Related]
14. [Recurrent depression in the elderly: what cognitive prognosis?]. Benoit M Encephale; 2010 Dec; 36 Suppl 5():S132-5. PubMed ID: 21211633 [TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of executive dysfunctions in unipolar major depressive disorder without psychotic symptoms and their changes during antidepressant treatment. Wagner S; Doering B; Helmreich I; Lieb K; Tadić A Acta Psychiatr Scand; 2012 Apr; 125(4):281-92. PubMed ID: 22007857 [TBL] [Abstract][Full Text] [Related]
16. Hippocampal visuospatial function and volume in remitted depressed patients: an 8-year follow-up study. Hviid LB; Ravnkilde B; Ahdidan J; Rosenberg R; Stødkilde-Jørgensen H; Videbech P J Affect Disord; 2010 Sep; 125(1-3):177-83. PubMed ID: 20219249 [TBL] [Abstract][Full Text] [Related]
17. Antidepressant drug action: a neuropsychological perspective. Harmer CJ Depress Anxiety; 2010 Mar; 27(3):231-3. PubMed ID: 20196098 [No Abstract] [Full Text] [Related]
18. Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder. Madhoo M; Keefe RS; Roth RM; Sambunaris A; Wu J; Trivedi MH; Anderson CS; Lasser R Neuropsychopharmacology; 2014 May; 39(6):1388-98. PubMed ID: 24309905 [TBL] [Abstract][Full Text] [Related]